LIFE SCIENCES LEADERSHIP AND BUSINESS STRATEGIES UNIVERSITY OF BASEL ADVANCED STUDIES STEINENGRABEN 21, 4051 BASEL SWITZERLAND MARCH 2 – 3, 2015 APRIL 15 – 16, 2015 Accredited by SwAPP/ SGPM INVITATION Leaders in the life sciences are regularly faced with difficult dilemmas and tough challenges. The key to outstanding leadership is deep understanding and awareness of oneself, one’s colleagues, one’s organisation, and one’s environment—coupled with the capacity to build relationships and trust, vision and strategic thinking about drivers for change, and decisive action and crisis management. Our Life Sciences Leadership and Business Strategies Course explores in theory and practice what it takes to be an effective leader. Participants will get the core management skills which are needed to fully leverage the human capital of their department or company. The course aims to fill the gaps between leadership and management, vision and reality, strategy design and implementation in the Life Sciences / Health / Insurance Industries. Hence, science-minded managers should be turned into capable business leaders. We are looking forward to welcoming you to this course. Prof. Dr. Thomas D. Szucs Dr. Annette Mollet Dr. Patricia Blank Director ECPM Head of Education & Training Senior Research Scientist COURSE OUTLINE This course offers the basic principles of innovation leadership and gives insight into legal and health economics, portfolio management, and regulatory and financial basics in life science. The course programme covers four days including presentations, company and industry relevant interactive teaching with case studies, practical exercises and short communication by participants. LEARNING OUTCOMES At the end of this module the student should be able to: 1.Understand basic principles of innovation leadership for profitable growth, results through speaking and listening, lead cross cultures, and communi- cation strategies, 2.Describe new tools and practices in bringing a new molecule to market, 3.Be capable to utilise basics of legal and health economics including constraints of conducting a successful biopharmaceutical business, 4.Recognise evolving expectations from the regulatory and financial environment, 5.Outline the basics in various types of alliances, valuation of technologies, portfolio management, joint ventures, partnerships, pricing of drugs, 6.Understand structuring successful collaborative arrangements between pharmaceutical companies, SMEs and universities, 7.Appraise the role and key competences and tasks of a CEO, including perspectives of an employee, a CEO and a board member. TEACHING FACULTY The teaching faculty consists of internationally and nationally renowned scientific and consultancy managers from life science organisations, government and academia. MARCH 2 – 3, 2015 DAY 1 (SUBJECT TO CHANGE) Trends and Future in Life Sciences Industries and the Crucial Role of Management Thomas D. Szucs, ECPM Basel Otto Schwarz, Actelion Allschwil Alexandra Goll, TVM Captial, Munich • • • • Leading Knowledge Workers – on becoming a business leader Issues and Perspectives in Pharmaceutical Research & Development Improving Organizational Performance Crisis management (types of crises, coping strategies, preventative measures) Financial Management: Macroeconomics and Microeconomics Capital Markets, Investments, Valuations Balances, and Economics Martin Austin, TransformRx Basel Chandra P. Leo, HBM Partners AG Zurich • Leading the Innovation Process: The Investor’s Perspective • Health Systems Economics and Trends in Health System Development: Economics of Drug Development DAY 2 The Role of a CEO and the Board Thomas D. Szucs, ECPM Basel Ulf Grawunder, CEO NBE-Therapeutics Basel David Ebsworth, former CEO Vifor Pharma AG and Galenica Ltd • Financial Management Control and the Physician’s Role and the Board Member’s View • Experiences and View of a CEO: Role, Key Competences and Tasks of a Biotech/ SME • Experiences and View of a CEO: Role, Key Competences and Tasks of Big Pharma • Panel discussion: Management Pearls of Wisdom Leadership: Motivating Global Teams, Social Competence Alex Khatuntsev, Actelion Allschwil Cesar Escrig, Novartis Pharma AG Basel Alexander Schuster, Mentavis Consulting London • • • • The Principles of Leadership and Motivation Leading High Performance Teams Applied Change Management Interactive Workshop “Organisational Change: Applied Change Management” APRIL 15 – 16, 2015 DAY 3 (SUBJECT TO CHANGE) Business Development: Portfolio Management and Market Access Manfred Heinzer, Roche Pharma Schweiz Reinach Valentina Sartori, McKinsey Zurich (invited) Anthony Hörning, Consulant, Basel Jorge Wernli, Vifor Glattbrugg • Portfolio Management and Growth Strategies • Pharma R&D and the Interface to Commercial: From Attrition Rates in the Pipeline to Value-Driven Development Models • Collaborations & Alliances • Pricing and Market Access Performance: How to Speed up Market Access and Optimize Pricing and Reimbursement Results? Legal Responsibilities and Negotiation Thomas D. Szucs, ECPM Basel Xavier Luria, Senior Independent Consultant London Judy Churchill, Language Consulting Services Ltd UK • Health Care Management: Corporate Governance and Legal Responsibilities for Reducing and Addressing Error • Strategic Approaches to Worldwide Regulation and Reimbursement • Negotiating and Communicating in a Multi-Cultural Environment DAY 4 Life-Cycle Management, Intellectual Property, and Licensing Hans Dettmers, LifeCycle Management Expert Basel Eric Notegen, F. Hoffmann-La Roche AG Basel Bertrand Lehuu, Aquapharm BioDiscovery Ltd. Edingburgh • Strategic Life Cycle Management • How to Protect Intellectual Property: Having the Vision to Make the Most of Invisible Assets • Elements of an Ideal Licensing Agreement: Effective Negotiation and Forming Alliances Across Borders ORGANISING INSTITUTION ECPM, Institute of Pharmaceutical Medicine, University of Basel Klingelbergstrasse 61, CH-4056 Basel, Switzerland Phone +41 61 267 1950, Fax +41 61 267 1948 www.ecpm.ch or [email protected] TITLE AND CREDIT POINTS This course is an elective module of the Master in Medicines Development (MMD) Programme but can also be booked as a stand-alone continuing education course. Successful participation is awarded 3 ECTS. COURSE FEE • CHF 3’750.– standard course fee • CHF 2’250.– for university employees and non for profit organisations The fee includes meeting materials, lunch, coffee. After registration you will receive an invoice. For short notice registration, please provide a copy of the money transfer at the registration desk. CANCELLATION Fees will be refunded, after deduction of a 30% administrative charge, if cancellation is received in writing (by email, letter or fax) by February 23, 2015. ECPM may transfer your registration to another member of your company. In the unlikely event the course is cancelled, our liability is limited to refunding workshop fees. Speakers are subject to change without notice. COURSE VENUE Advanced Studies, Steinengraben 22, 4051 Basel, Switzerland From Basel Bahnhof SBB / Swiss Railway Station: Take bus no 30 (leaving in front of Confiserie Bachmann, direction Badischer Bahnhof) to „Steinenschanze“ (1 stop, 2 min). From Basel Badischer Bahnhof / German Railway Station: Take bus no 30 (direction Basel Bahnhof SBB) to „Steinenschanze“ (20 min).